Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive

FDA Fast Track designation supports accelerated development and expedites regulatory reviewNorovirus is responsible for an ...

Cocrystal Pharma shares soar after FDA grants fast track status to CDI-988

Cocrystal Pharma, Inc. COCP shares are trading higher Thursday after the company announced that it has received Fast Track ...
MPR

Oral Antiviral CDI-988 Earns FDA Fast Track for Norovirus Treatment

The Food and Drug Administration (FDA) has granted Fast Track designation to CDI-988 for treatment and prophylaxis of norovirus infection.

Haugen Academy Expands Education Portfolio with Clinical Documentation Integrity (CDI) Training

New CDI-specific education helps align clinical indicators, provider documentation, and compliant coding practices.